date:Jan 22, 2013
fident that we can reach the long-term average sales growth target of more than 10%, although not until 2015. Meanwhile, profitability will remain at current levels, and we are raising our target for EBIT margin to more than 24%. The ROIC target is confirmed as more than 22%. The companys strategy is unchanged and, under the leadership of the new president and CEO Peder Holk Nielsen, Novozymes will continue to focus on innovation, partnerships and sustainability.
Food and beverages enzymes sal